We are live on ! Find out more
MIM

Martin Investment Management Portfolio holdings

AUM $300M
1-Year Est. Return 6.05%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$390M
AUM Growth
-$17.3M
Cap. Flow
-$27.2M
Cap. Flow %
-6.98%
Top 10 Hldgs %
59.66%
Holding
52
New
4
Increased
6
Reduced
30
Closed
4

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$20.8M
2
AZO icon
AutoZone
AZO
+$6.64M
3
FANG icon
Diamondback Energy
FANG
+$4.12M
4
XOM icon
ExxonMobil
XOM
+$1.61M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$55.3K

Top Sells

Rank Stock Value
1
HLN icon
Haleon
HLN
+$37M
2
VRSN icon
VeriSign
VRSN
+$5.95M
3
HP icon
Helmerich & Payne
HP
+$4.61M
4
NVO
Novo Nordisk
NVO
+$1.27M
5
TM icon
Toyota
TM
+$944K

Sector Composition

Rank Sector Weight
1 Healthcare 34.26%
2 Technology 25.58%
3 Consumer Discretionary 10.98%
4 Financials 10.03%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
1
Novo Nordisk
NVO
$228B
$41M 10.52%
287,212
-9,569
-3% -$1.27M
CHKP icon
2
Check Point Software Technologies
CHKP
$13.1B
$26.4M 6.78%
160,132
-5,449
-3% -$849K
NVS icon
3
Novartis
NVS
$301B
$24.4M 6.25%
228,936
-7,864
-3% -$789K
TM icon
4
Toyota
TM
$227B
$24.2M 6.2%
117,964
-4,266
-3% -$944K
ALC icon
5
Alcon
ALC
$33.9B
$23.3M 5.97%
261,236
-9,116
-3% -$778K
AAPL icon
6
Apple
AAPL
$4.9T
$22.2M 5.69%
105,206
-3,211
-3% -$599K
AZN icon
7
AstraZeneca
AZN
$266B
$21.6M 5.53%
+138,295
New +$20.8M
SONY icon
8
Sony
SONY
$134B
$17.7M 4.55%
1,044,420
-23,680
-2% -$392K
MA icon
9
Mastercard
MA
$510B
$17.1M 4.39%
38,752
-1,528
-4% -$696K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.08T
$14.7M 3.77%
80,689
-3,420
-4% -$577K
BKNG icon
11
Booking.com
BKNG
$150B
$11.2M 2.87%
70,525
-2,650
-4% -$393K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.1T
$10.7M 2.75%
26,375
-918
-3% -$375K
AXP icon
13
American Express
AXP
$228B
$10.1M 2.6%
43,793
-1,640
-4% -$380K
TMO icon
14
Thermo Fisher Scientific
TMO
$214B
$9.32M 2.39%
16,848
-627
-4% -$359K
NXPI icon
15
NXP Semiconductors
NXPI
$61.8B
$8.66M 2.22%
32,176
-826
-3% -$213K
VRSK icon
16
Verisk Analytics
VRSK
$26.1B
$8.29M 2.13%
30,767
-998
-3% -$244K
WAB icon
17
Wabtec
WAB
$49.4B
$8.1M 2.08%
51,260
-1,255
-2% -$201K
GD icon
18
General Dynamics
GD
$103B
$7.83M 2.01%
27,002
-1,188
-4% -$348K
SYK icon
19
Stryker
SYK
$133B
$7.29M 1.87%
21,424
-813
-4% -$275K
LHX icon
20
L3Harris
LHX
$50.7B
$7.08M 1.82%
31,512
-1,097
-3% -$237K
AME icon
21
Ametek
AME
$55B
$6.97M 1.79%
41,817
-1,073
-3% -$185K
ACN icon
22
Accenture
ACN
$99.9B
$6.91M 1.77%
22,773
-746
-3% -$229K
ROP icon
23
Roper Technologies
ROP
$38.5B
$6.85M 1.76%
12,147
-551
-4% -$297K
AZO icon
24
AutoZone
AZO
$49.1B
$6.72M 1.72%
+2,267
New +$6.64M
PG icon
25
Procter & Gamble
PG
$335B
$6.68M 1.72%
40,531
-1,384
-3% -$226K
1
2 3

Similar funds

JGIA
Jackson Grant Investment Advisers Stamford, Connecticut $300M AUM 13.94% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
KEM
Kimmeridge Energy Management New York $299M AUM 36.96% 1-Year Est. Return
I
InterCapital Austin, Texas $299M AUM
GB
Goepper Burkhardt Greenville, South Carolina $299M AUM 12.16% 1-Year Est. Return
CG
Corundum Group Colorado Springs, Colorado $299M AUM 20.66% 1-Year Est. Return
UCB
United Community Bank Greenville, South Carolina $300M AUM 14.66% 1-Year Est. Return
RP
Riverwater Partners Milwaukee, Wisconsin $300M AUM 26.4% 1-Year Est. Return

Martin Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Martin Investment Management held 52 positions worth $390M, down 4.3% from $407M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Martin Investment Management withdrew a net $27.2M in Q2 2024, closing 4 positions and reducing 30 holdings. Its most notable exit was VeriSign, an estimated $5.95M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Martin Investment Management opened a new position in AstraZeneca worth $21.6M.

  • Martin Investment Management's largest Q2 2024 buy was AstraZeneca: 138,295 shares worth $21.6M.
  • Martin Investment Management added most to Alphabet (Google) Class C in Q2 2024, an estimated $55.3K increase.
  • Martin Investment Management's biggest Q2 2024 reduction was Haleon, cutting an estimated $37M.
  • Martin Investment Management fully exited VeriSign in Q2 2024, selling an estimated $5.95M.
  • Martin Investment Management's ten largest holdings make up 60% of its $390M portfolio in Q2 2024.
  • Martin Investment Management opened 4 new positions and closed 4 in Q2 2024.
  • Martin Investment Management's portfolio value fell 4.3% quarter-over-quarter to $390M.

Based on Martin Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.